Uptake and metabolism of novel biodegradable poly(glycerol-adipate) nanoparticles in DAOY monolayer

被引:50
作者
Meng, W.
Parker, T. L.
Kallinteri, P.
Walker, D. A.
Higgins, S.
Hutcheon, G. A.
Garnett, M. C. [1 ]
机构
[1] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England
[2] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England
[3] Queens Med Ctr, Nottingham NG7 2UH, England
[4] Liverpool John Moores Univ, Sch Chem & Pharm, Liverpool L3 5UX, Merseyside, England
基金
英国生物技术与生命科学研究理事会;
关键词
parenteral delivery; biodegradable polymer; poly (glycerol-adipate); nanoparticle uptake; nanoparticle degradation;
D O I
10.1016/j.jconrel.2006.09.014
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A useful route for the development of antitumour therapies is by creating improved methods for delivering therapeutic agents to tumour cells or subcellular compartments and increasing retention of drugs within target cells. In this study, we have characterized nanoparticle (NP) uptake and metabolism by DAOY cells, a human medulloblastoma cell line. NPs were formed from a novel polymer, poly (glycerol-adipate) (PGA), containing Rhodamine B Isothiocyanate (RBITC) as a fluorescent marker. It was observed that the cellular uptake of NPs depends on the incubation time and the concentration of NPs in the culture medium. The studies of retention and metabolism of NPs within cells indicated that 1) faster degradation of NPs within cells compared with that in cell culture medium in vitro; 2) a small fraction of NPs were recycled back to the outside of cell, whereas most NPs entered endosomes and lysosomes; and 3) recycled NPs were re-taken up in the following 2 h incubation time. These studies thus suggested that PGA NPs could be used for localising therapeutic agents into cells, and could provide prolonged drug effects because of their long sustained release in physiological conditions and their rapid release when taken up into cells. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 22 条
[1]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[2]   Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (02) :189-198
[3]   Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin [J].
Borsi, JD ;
Csaki, C ;
Ferencz, T ;
Oster, W .
ANTI-CANCER DRUGS, 1996, 7 (01) :121-126
[4]   Release of dexamethasone from PLGA nanoparticles entrapped into dextran/poly(vinyl alcohol) hydrogels [J].
Cascone, MG ;
Pot, PM ;
Lazzeri, L ;
Zhu, ZH .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2002, 13 (03) :265-269
[5]  
CASTELLO MA, 1990, AM J PEDIAT HEMATOL, V12, P297
[6]  
Duncan R, 1998, ANN ONCOL, V9, P39
[7]   NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[8]  
GARNETT MC, 1986, EUR J CELL BIOL, V41, P214
[9]   FLUID-PHASE ENDOCYTOSIS BY ISOLATED RAT ADIPOCYTES [J].
GIBBS, EM ;
LIENHARD, GE .
JOURNAL OF CELLULAR PHYSIOLOGY, 1984, 121 (03) :569-575
[10]   PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug [J].
Govender, T ;
Stolnik, S ;
Garnett, MC ;
Illum, L ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :171-185